The ADA is dropping its recommendation for Avandia and now recommends a back-to-basics approach for treating type 2 diabetes

December 2008

The ADA is dropping its recommendation for Avandia and now recommends a back-to-basics approach for treating type 2 diabetes.

They now break diabetes therapies into two tiers...and suggest sticking with the older, cheaper ones for most patients.

Tier 1: Lifestyle changes, metformin, sulfonylureas, and insulin should be the core therapies for type 2 diabetes.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote